Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAICHIRONA-induced cytokine and chemokine responses and association with side effects
jRCTs031240519Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Primary: Cytokine and chemokine production after DAICHIRONA stimulation by side effect categories and severities. Started Dec 2024; status: active, not recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs031240519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240519.